About
myBiometry develops a patented sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) to predict and prevent asthma attacks by analyzing biological and environmental data via a mobile app.
Explore myBiometry's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.